NNEPQIN Guideline for Screening for Use of Alcohol, Tobacco and Drugs of Abuse in Pregnancy. March 2014
|
|
- Phillip Clyde Tucker
- 8 years ago
- Views:
Transcription
1 The following guidelines are intended only as a general educational resource for hospitals and clinicians, and are not intended to reflect or establish a standard of care or to replace individual clinician judgment and medical decision making for specific healthcare environments and patient situations. NNEPQIN Guideline for Screening for Use of Alcohol, Tobacco and Drugs of Abuse in Pregnancy March 2014 Approximately 12% of pregnant women report the use of alcohol within the last month. Four percent of pregnant women report the use of illicit drugs. 16.5% report continuing smoking tobacco while pregnant. The rate of illicit drug use is higher in women age (1). The continued use of alcohol is more prevalent in women that are over age 35, of white race, college educated, married and obtaining care from a private physician (2). Obstetrical care providers have a professional obligation to screen all patients for substance abuse in pregnancy (3). Identification of substance abuse can lead to appropriate referral and treatment for the mother, while possibly mitigating risk for the fetus. Several screening methods and tools have been proposed and validated, but the routine use of these has in some cases been difficult to incorporate into practice. Communication with patients about drug and alcohol use is often difficult and requires additional skill and time. There can be confusion about legal reporting obligations. Often, treatment options are not clear or obtainable. Unit Structure Each hospital should develop policy and procedure guidelines that employ universal screening for at-risk drug and alcohol use, as well as continued tobacco use in pregnancy. These guidelines should include a description of screening methods, methods of notification of members of the care team, as well as legal authorities when necessary, and resources for ancillary support, education and treatment. Hospital screening programs should be coordinated with outpatient screening during the antenatal period. An important aspect of screening and counseling is that is performed in a non-judgmental, nonpunitive manner. Substance abuse and dependence are medical conditions, not moral problems. Using respectful communication that engages the patient in ongoing care and screening with informed consent are techniques that nurture the therapeutic relationship between provider and patient. 1
2 Definitions At-Risk Behaviors: Behaviors or circumstances that indicate a substantially higher likelihood of the use of alcohol, tobacco, or illicit substances, as identified by screening. Substance Use Disorder: A recurring pattern of alcohol or other drug use which substantially impairs a person s functioning in one or more important life areas such as familial, employment, psychological, legal, social, or physical. Any use by youth is considered a use disorder. (4) Substance Dependence: A primary chronic disease leading to clinically significant impairment or distress, including physical and psychological dependence as evidenced by tolerance, withdrawal, and unsuccessful attempts to cut down or control use (4). Role of the Obstetrical Care Provider The role of the obstetrical care provider in the process of evaluation of patients for substance abuse has been suggested by ACOG to include (3, 5): Learn and incorporate into routine practice the process of screening, brief intervention and referral to treatment (SBIRT), in order to provide patient benefit and nurture the therapeutic relationship. Encourage healthy behaviors by providing appropriate information and education. Adhere to safe prescribing practices. Identify referral resources and develop other members of the health care team to assist with counseling, referral and treatment. Evaluate at-risk patients for associated medical and social problems such as partner violence, sexually transmitted diseases, and other medical complications of substance abuse such as cardiac and respiratory compromise. Be aware of local legal reporting obligations. Screening Considerations Screening for at-risk use of alcohol, drugs and tobacco is carried out by asking directed questions. The use of a standardized questionnaire at regular intervals in pregnancy is recommended as the most effective method of implementing screening into routine practice. Biochemical testing should never be employed as a stand alone screening method. Several questionnaires have been developed for use as screening tools, but there is not consensus regarding which tool is most ideal for use in the pregnant population. Various tools may be too sensitive, or too specific, may not be ideal for pregnant populations, or may screen for alcohol only, and not other substances. Some tools may be proprietary, while others may not be recognized by regulatory agencies as valid for billing purposes. Each unit must determine which screening tool is optimal, given the local needs and circumstances. A comprehensive description of screening tools can be found at (6): Several screening questionnaires have been recommended for use in pregnant women. The T- ACE (Tolerance, Annoyance, Cut Down, Eye Opener) (7) and TWEAK (Tolerance, Worried, Eye-openers, Amnesia, K[C] Cut Down) (8) are two screening questionnaires that have been 2
3 shown to be effective in pregnant populations, but they primarily screen for heavy alcohol use. Chasnoff has validated a questionnaire that screens for drug and alcohol use, as well as at-risk behaviors or circumstances (4Ps plus) (9, 10). As such, the sensitivity of the screen is higher (more identified as at-risk), but the specificity is lower (fewer actually exhibit substance abuse). The 5Ps is a modification of the 4Ps (11) validated questionnaire, developed by the Massachusetts Institute of Health and Recovery, designed to be a brief 6-question screen for tobacco, alcohol and drug use(12). The AUDIT-C is an abbreviated 3 question screen for at-risk alcohol use that has been validated for use in female populations (13). It does not screen for drug use. The DAST-10 is a 10- question drug abuse screen, validated for use in a general female population (14). As validated questionnaires, their use in screening programs, when combined with brief intervention, is recognized by CPT and reimbursement may be available. Yonkers, et al have described an analysis of multiple screening questions and suggest that directed questions about past use of marijuana, pre-pregnancy use of alcohol or drugs, and a perceived need to cut down on use are the most sensitive at identifying an at-risk patient (SURP- P) (15). Biochemical testing of pregnant patients is most practically achieved through urine toxicology testing. Urine toxicology testing has several limitations, including those related to the short time interval for detection of the presence of a substance (1-3 days in most cases), false negative and false positive results, and susceptibility to tampering and falsification. There is conflicting evidence regarding the clinical utility of universal urine toxicology testing as part of a screening program (16, 17, 18, 19, 20, 21). Urine drug testing often identifies patients using substances when they do not admit to use, and this is especially the case in high risk populations. Some prenatal screening programs incorporate routine urine toxicology testing along with the use of screening questionnaires (22). Others recommend urine toxicology testing when a woman denies use, but high risk circumstances are present (23). Biochemical testing should not be used to replace or substitute for other forms of screening, but rather should be used as an adjunct to a comprehensive program of screening and referral. Circumstances associated with substance abuse include (23): Partner is a substance abuser Legal problems and arrests Multiple missed appointments Stigmata of drug use: perforated nasal septum, intravenous track scars, skin abscesses Homelessness Family history of drug or alcohol abuse History of/or ongoing psychiatric treatment Previously delivered children not living with the mother Unexplained history of obstetrical or neonatal problems: abruption of placenta, IUGR, prematurity Late presentation for prenatal care History of/or ongoing treatment for chronic pain 3
4 Recent study has shown that some women are mistrustful of providers efforts to discover drug use, especially when urine testing is used (24). Interviews with substance using women revealed they expected untoward consequences of being identified, including feelings of maternal failure, judgment by providers, and reports to legal authorities. As a result women took steps to protect themselves, including avoiding or disengaging from prenatal care. All screening methods should be employed with informed consent of the patient. The proper management of the patient with a positive screen will foster a relationship of trust. Information regarding positive screening, drug testing results or a diagnosis of substance abuse should be communicated to the patient privately, and then only to the necessary members of the health care team. Patients should be confidentially counseled about the dissemination of information regarding the results of screening. Each hospital should be able to identify community resources for referral and treatment. A comprehensive guideline for screening pregnant women for substances of abuse has been developed by the Vermont Child Health Improvement Program and is available at: (23) Screening the Pregnant Patient for Substance Abuse All pregnant patients should undergo screening for the use of tobacco, alcohol or other drugs using one of several validated questionnaires. NNEPQIN offers the following methodology for the use of the 5Ps Prenatal Substance Abuse Screen for Alcohol, Drugs and Tobacco (Appendix 2) (11, 12). 1. All pregnant patients will undergo the 5Ps screen at the initial obstetrical visit, and upon admission to labor and delivery: Did any of your parents have a problem with using alcohol or drugs? Do any of your friends (peers) have problems with drug or alcohol use? Does your partner have a problem with drug or alcohol use? In the past have you had difficulty in your life due to alcohol or other drugs, including prescription medications? Present: In the past month, how often did you drink beer, wine, wine cooler or liquor or use any king of drug? (How many times a day, week or month.) How much did you smoke before you knew you were pregnant? 2. A positive response to any of the questions on the 5Ps is a positive screening result, and should trigger further directed questioning. A more comprehensive history of drug or alcohol use is needed to determine whether a substance use disorder or substance abuse is present. Evaluation of the perceived health and emotional effects of substance use is an important part of history taking. 3. A urine toxicology test should be considered when the maternal patient presents with risk factors including, but not limited to, the following: No or inadequate prenatal care. Exhibited signs and symptoms of drug and/or alcohol use or withdrawal. Drug seeking behavior, repeated use of prescription narcotics. 4
5 Personal history of domestic violence, incarceration, or previous DCF/DCYF referral. Maternal history of Hepatitis B/C, HIV-positive status, or active STD s. Unexplained medical complications of pregnancy such as: preterm labor, placenta abruption, IUGR, and hypertension. 4. All patients are monitored during prenatal care for risk factors as noted above, and should they develop, repeat screening with or without urine drug testing should be performed. 5. All necessary members of the health care team should be informed of the results of screening. A member of the health care team should notify the patient of the results of testing and discuss any implications for care. 6. Patients with positive toxicology results should be counseled about the risks and benefits of breastfeeding. 7. If the patient with a positive toxicology test denies using, consideration should be given to performing confirmatory testing. Continue with the policy and procedure as outlined for positive screen results. 8. All members of the healthcare team are responsible for reporting suspected abuse or neglect of children to the DCF/DCYF within 24 hours. Positive toxicology test results will be reported to DCF/DCYF by a member of the healthcare team. See Appendix 4 for screening algorithm Managing the Results of Screening Screening methods are primarily designed to identify an increased risk of abuse of alcohol, illicit substances or tobacco. A positive screen does not necessarily identify substance abuse or significant use that would confer risk to the mother or fetus. A positive screen should be followed by: More directed inquiry about use of substances and their effects on the patient s physical and emotional health. Education of the patient about the health effects of substance use, and recommendation that she either stop using or seek treatment if drug dependent. An assessment of preparedness for cessation or treatment. An assessment of associated medical and social problems. Referral for directed counseling and treatment, as indicated. ACOG suggests that obstetrical providers learn the skills of brief intervention and active referral to treatment, as actions that can direct and encourage substance abusing patients to engage in treatment (3). The Boston University School of Public Health has developed an effective program of algorithms, tools and demonstration videos that can be employed to learn these skills in the clinic or hospital setting (25). The Brief Negotiated Interview (BNI) helps providers quickly explore a patient s motivation to change behavior, while eliciting action steps from the patient. The Active Referral to Treatment (ART) involves initiating the treatment plan with the assistance of the patient. The BNI ART Institute web site may serve as a resource for providers to offer these important intervention and referral services: 5
6 Proposed Performance Measure The percentage of patients for whom screening and documentation has been completed upon admission for labor and delivery. Appendix: 1. Criteria for Evaluation of Studies 2. 5P s Prenatal Substance Abuse Screen for Alcohol, Drugs and Tobacco. 3. AUDIT-C Questionnaire 4. DAST-10 Questionnaire 5. Algorithm for Substance Abuse Screening in Pregnancy Appendix 1 Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventative Services Task Force I Evidence obtained from at least one properly designed randomized controlled trial. II 1 Evidence obtained from well designed controlled trials without randomization. II 2 Evidence obtained from well designed cohort or case control analytic studies, preferably from more than one center or research group. II 3 Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence. III Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees. Based on the highest level of evidence found in the data, recommendations are provided and graded according to the following categories: Level A Recommendations are based on good and consistent scientific evidence. Level B Recommendations are based on limited or inconsistent scientific evidence. Level C Recommendations are based primarily on consensus and expert opinion. 6
7 Appendix 2 5 Ps: Prenatal Substance Abuse Screen for Alcohol, Drugs and Tobacco. 1. Did any of your parents have a problem with using alcohol or drugs? No Yes No response If yes, explain/comments: 2. Do any of your friends (peers) have problems with drug or alcohol use? No Yes No response If yes, explain/comments: 3. Does your partner have a problem with drug or alcohol use? No Yes No response If yes, explain/comments: 4. In the past have you had difficulty in your life due to alcohol or other drugs, including prescription medications? No Yes No response Comment: 5. Present: In the past month, how often did you drink beer, wine, wine cooler or liquor or use any king of drug? (How many times a day, week or month.) No use Has used Comment: 6. How much did you smoke before you knew you were pregnant? packs a day. Comment: Date/Time: Name (Print): Signature: From the Massachusetts Institute of Health and Recovery 7
8 Appendix 3 AUDIT-C Questionnaire 1. How often did you have a drink containing alcohol in the past year? Never (0 points) If you answered never, score questions 2 and 3 as zero. Monthly or less (1 point) 2 to 4 times a month (2 points) 2 or 3 times per week (3 points) 4 or more times a week (4 points) 2. How many drinks did you have on a typical day when you were drinking in the past year? 1 or 2 3 or 4 5 or 6 7 to 9 10 or more (0 points) (1 point) (2 points) (3 points) (4 points) 3. How often did you have 6 or more drinks on one occasion in the past year? Never Less than monthly Monthly Weekly Daily or almost daily (0 points) (1 point) (2 points) (3 points) (4 points) The maximum score is 12. A score of 4 identifies 86% of men who report drinking above recommended levels or meets criteria for alcohol use disorders. A score of > 2 identifies 84% of women who report hazardous drinking or alcohol use disorders. WHO Publication 8
9 Appendix 4 DAST-10 Questionnaire 1. Have you used drugs other than those required for medical No Yes reasons? 2. Do you abuse more than one drug at a time? No Yes 3. Are you unable to stop using drugs when you want to? No Yes 4. Have you ever had blackouts or flashbacks as a result of drug No Yes use? 5. Do you ever feel bad or guilty about your drug use? No Yes 6. Does your spouse (or parents) ever complain about your No Yes involvement with drugs? 7. Have you neglected your family because of your use of drugs? No Yes 8. Have you engaged in illegal activities in order to obtain drugs? No Yes 9. Have you ever experienced withdrawal symptoms (felt sick) No Yes when you stopped taking drugs? 10. Have you had medical problems as a result of your drug use (e.g. memory loss, hepatitis, convulsions, bleeding)? No Yes Skinner, Harvey A. and the Center for Addiction and Mental Health, Toronto Canada 9
10 Appendix 4 Algorithm for Substance Abuse Screening in Pregnancy Initial Visit for Prenatal Care Screen All with 5Ps Questions. If Antenatal Risk Factors* Present, Order Urine Drug Screen and Perform Ongoing Assessment with Periodic Repeat Screening. Negative Screen Substance Abuse or Dependence Identified Routine Prenatal Care Monitor All for Antenatal Risk Factors* Associated With Substance Use. If Present, Repeat 5Ps and Consider Urine Drug Screening. Comprehensive Assessment and Treatment. Monitor for Relapse. Fetal Monitoring as Indicated. Urine Drug Screen at Regular Intervals and on Any Admission Admission for Delivery Negative Screen, No Complications Routine Care and Discharge Screen All with 5Ps Questions If Antenatal Risk Factors* Present, Order Urine Drug Screen Substance Abuse or Dependence Identified Comprehensive Assessment and Treatment, NAS Scoring Declines Screening, or Negative Screening, but Presence of Neonatal Complications Associated with Substance Use (Positive NAS Scoring, Anomalies Suggestive of Drug or Alcohol Exposure, Vascular Accidents, MI, NEC at Term): Perform Maternal and Neonatal Biochemical Screening and Start/Continue NAS Scoring. *Antenatal Risk Factors: No or Inadequate Prenatal Care, Exhibited Signs and Symptoms of Drug and/or Alcohol Use or Withdrawal, Drug Seeking Behavior, Repeated Use of Prescription Narcotics, Personal History of Domestic 10 Violence, Incarceration, or Previous DCF/DCYF Referral, Hepatitis B/C, HIV-Positive Status, or Active STD s, Unexplained Preterm Labor, Placenta Abruption, IUGR, Hypertension.
11 References: 1. Substance Abuse and Mental Health Administration SAMHSA. Results from the 2005 National Survey on Drug Use and Health; National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS, Publication No. SMA , Rockville, MD, Diana Cheng, MD, Laurie Kettinger, MS,et al. Alcohol Consumption During Pregnancy, Prevalence and Provider Assessment. Obstet Gynecol 2011; 117: 212. (Level III) 3. ACOG Committee Opinion #442: At-Risk Drinking and Illicit Drug Use: Ethical Issues in Obstetric and Gynecologic Practice. Dec (Level III) 4. Diagnostic and Statistical Manual of Mental Disorders, 4 th Edition, (DSM-IV). 5. ACOG Committee Opinion #473: Substance Abuse Reporting and Pregnancy: The Role of the Obstetrician-Gynecologist. January 2011 (Level III) 6. From the Virgina Department of Behavioral Health and Developmental Services, Accessed 1/13/ Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989;160: (Level II-2) 8. Chang G, Wilkins-Haug L, Berman S, Goetz MA, Behr H, Hiley A. Alcohol use and pregnancy: improving identification. Obstet Gynecol 1998;91: (Level II-2) 9. Chasnoff IJ, Wells AM, McGourty RF, Bailey LK. Validation of the 4P s Plus screen for substance use in pregnancy. J Perinatol 2007;27:744. (Level II-2) 10. Chasnoff IJ, McGourty RF, et al. The 4P s Plus Screen for Substance Use in Pregnancy: Clinical Application and Outcomes. J Perinatol 2005;25:368. (Level II-2) 11. Ewing H. A practical guide to intervention in health and social services with pregnant and postpartum addicts and alcoholics: theoretical framework, brief screening tool, key interview questions, and strategies for referral to recovery resources. Martinez (CA): The Born Free Project, Contra Costa County Department of Health Services; From the Massachusetts Institute of Health and Recovery, Accessed 1/13/ Bush, K, Kivlahan, DR, et al. The AUDIT Alcohol Consumption Questions (AUDIT-C): An effective brief screening test for problem drinking. Arch Internal Med. 1998; 3: Skinner, HA. The Drug Abuse Screening Test. Addict Behav 1982; 7:
12 15. Yonkers, KA, MD, Gotman, N, MS, et al. Screening for Prenatal Substance Use, Development of the Substance Use Risk Profile-Pregnancy Scale. Obstet Gynecol 2010; 116: 827 (Level II-2) 16. Lester BM, ElSohley M, et al. The Maternal Lifestyle Study: Drug Use by Meconium Toxicology and Maternal Self-Report. Pediatrics 2001;107;309 (Level II-2) 17. Ostrea EM, Knapp, DK, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatric 2001;138:344 (Level II-2) 18. Tassiopoulos K, Read JS, et al. Substance Use in HIV-Infected Women During Pregnancy: Self-Report Versus Meconium Analysis. AIDS Behav 2010;14:1269 (Level II-2) 19. El Maroon H, Temeier H, et al. Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: the generation R study. Eur Addict Res 2011;17:37 (Level II-2) 20. Grekin ER, Lamm P, et al. Drug Use During Pregnancy: Validating the Drug Abuse Screening Test Against Physiological Measures. Psych Addict Behav 2010;24:719 (Level II-2) 21. Christmas, JT, Kinsley, JS, et al. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance abuse. Obstet Gynecol 1992;80:750 (Level II-2) 22. Goler, NC, Armstrong, MA, et al. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinat 2008;28:597 (Level II-2) 23. Meyer, M, MD, Mandell, T, MD, et al. Screening for Substance Abuse During Pregnancy, Guidelines for Screening. Vermont Child Health Improvement Program (VCHIP) (Level III) At: ELINES.pdf 24. Roberts, SC, Neru-Jeter, A. Women s perspectives on screening for alcohol and drug use in prenatal care. Womens Health Issues. 2010; 20: (Level III) 25. Boston University School of Public Health, The BNI ART Institute. Available at: 12
CAGE. AUDIT-C and the Full AUDIT
CAGE In the past have you ever: C tried to Cut down or Change your pattern of drinking or drug use? A been Annoyed or Angry because of others concern about your drinking or drug use? G felt Guilty about
More informationSubstance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
More informationDoc Dial-in Discussion Series
Doc 2 Doc Dial-in Discussion Series Session 3: Universal Screening for Unhealthy Alcohol and Other Drug (AOD) Use Learning Objectives: (1) Understand the concept of universal screening (2) Learn how to
More informationHow To Diagnose And Treat An Alcoholic Problem
guideline for identification and treatment of alcohol abuse/dependence in primary care This guideline is informational in nature and is not intended to be a substitute for professional clinical judgment.
More informationSBIRT: Behavioral Health Screenings & Patient- Centered Care. Presented By: Zoe O Neill July 24, 2013
SBIRT: Behavioral Health Screenings & Patient- Centered Care Presented By: Zoe O Neill July 24, 2013 Welcome! Type questions into the Questions Pane Patient-Centered Primary Care Institute History and
More informationIdentifying and Managing Substance Use During Pregnancy
Identifying and Managing Substance Use During Pregnancy Joseph B. Landwehr, Jr., MD Director, Perinatal Center IU Health Ball Memorial Hospital OBJECTIVES Overview of illicit drug use in pregnant women
More informationThe Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures
The Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures by R. Louise Floyd, DSN, RN; Brian W. Jack, MD; Robert Cefalo, MD, PhD; Hani Atrash, MD, MPH; Jeanne Mahoney, BSN,
More informationInstitute for Health and Recovery Integrated Screening Tool
Institute for Health and Recovery Integrated Screening Tool Women s health can be affected by emotional problems, alcohol, tobacco, other drug use, and domestic violence. Women s health is also affected
More informationCollaborative Care for Pregnant Women with Substance Use Disorders
Collaborative Care for Pregnant Women with Substance Use Disorders Alane O Connor DNP Maine Dartmouth Family Medicine Residency MaineGeneral Medical Center Dartmouth Medical School Vanderbilt University
More informationManagement of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute
Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute 1 Webinar Objectives Describe SBIRT approach to manage substance use in pregnancy
More informationMassachusetts Department of Public Health Guidelines for Community Standard for Maternal/Newborn Screening For Alcohol/Substance Use
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619 DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT
More informationNC Perinatal & Maternal Substance Abuse Initiative
NC Perinatal & Maternal Substance Abuse Initiative NC Division of MH/DD/SAS Community Policy Management Best Practice Team Starleen Scott Robbins, LCSW Illicit drug use among pregnant women in the U.S.
More informationSubstance-Exposed Newborns
Substance-Exposed Newborns State of Oklahoma 2013 Substance-Exposed Newborns State of Oklahoma 2013 Legal Background Federal guidelines in the Child Abuse Prevention and Treatment Act (CAPTA) require states
More informationScreening, Brief Intervention and Referral to Treatment (SBIRT) for Substance Use: A Public Health Approach. Joan Dilonardo, Ph.D., R.
Screening, Brief Intervention and Referral to Treatment (SBIRT) for Substance Use: A Public Health Approach Joan Dilonardo, Ph.D., R.N What is SBIRT? Some definitions Screening: a preliminary systematic
More informationProvider Training. Behavioral Health Screening, Referral, and Coding Requirements
Provider Training Behavioral Health Screening, Referral, and Coding Requirements Training Outline I. Behavioral Health Screening Requirements and Referrals II. Healthy Behaviors Substance and Alcohol Abuse
More informationColumbia Addictions Center
Columbia Addictions Center Eileen Dewey, L.C.S.W.-C Director Date: Client Name: Date of Birth: Address: City: State: Zip: Home #: Cell #: E-mail: Preferred contact (circle one): home # cell # e-mail Emergency
More informationAlcohol use during pregnancy is associated with a
Alcohol Consumption During Pregnancy Prevalence and Provider Assessment Diana Cheng, MD, Laurie Kettinger, MS, Kelechi Uduhiri, MD, MPH, and Lee Hurt, MS, MPH OBJECTIVE: To estimate the prevalence of prenatal
More informationSubstance Abuse Screening
The Goal of Substance Abuse Screening The goal of substance abuse screening is to identify individuals who have or are at risk for developing alcohol or drug-related problems, and within that group, identify
More information3/31/2015. Objectives. Alcohol. Long term effects. Substance abuse increases the risk of: Substance Abuse in Pregnancy
Objectives Substance Abuse in Pregnancy Basics of screening and counseling Minako Watabe, MD Obstetrics and Gynecology Ventura County Medical Center 1) Discuss the risks of alcohol, tobacco, and drug use
More informationKarla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center
Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center 1 in 4 Americans will have an alcohol or drug problems at some point in their lives. The number of alcohol abusers and addicts
More informationScreening and Brief Intervention for Unhealthy Alcohol and Other Drug Use in Primary Care
Screening and Brief Intervention for Unhealthy Alcohol and Other Drug Use in Primary Care Richard Saitz MD MPH FACP FASAM Professor of Medicine & Epidemiology Clinical Addiction Research and Education
More informationA PRELIMINARY EVALUATION OF SBIRT IMPLEMENTATION IN THE COLORADO STATE EMPLOYEE ASSISTANCE PROGRAM
A PRELIMINARY EVALUATION OF SBIRT IMPLEMENTATION IN THE COLORADO STATE EMPLOYEE ASSISTANCE PROGRAM DECEMBER, 2010 FOR FURTHER INFORMATION, PLEASE CONTACT: MELISSA RICHMOND, PH.D. OMNI INSTITUTE 899 LOGAN
More informationHow To Stop A Pregnant Addict From Getting A Jail Sentence For Drug Use
Case: 3:14-cv-00870-jdp Document #: 14-9 Filed: 01/07/15 Page 1 of 6 APPENDIX 8 Case: 3:14-cv-00870-jdp Document #: 14-9 Filed: 01/07/15 Page 2 of 6 AMERICAN MEDICAL ASSOCIATION Pregnant women will be
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationThe Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
More informationAlcohol Use in Pregnancy: Criminal Activity or Public Health Issue?
Alcohol Use in Pregnancy: Criminal Activity or Public Health Issue? Susan Kendig, JD, MSN, WHNP-BC, FAANP Director of Policy, National Association for Nurse Practitioners in Women s Health (NPWH) This
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationUTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) GENERAL PROGRAM REQUIREMENTS
UTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) Program Name Reviewer Name Date(s) of Review GENERAL PROGRAM REQUIREMENTS 2014 Division
More informationChapter 12: Substance Abusing Pregnant Women, Substance Exposed Children and Their Families
Chapter 12: Substance Abusing Pregnant Women, Substance Exposed Children and Their Families Introduction Substance abuse includes the abuse of alcohol, tobacco and other drugs. Prenatal substance abuse
More informationIn Brief UTAH. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
UTAH Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males and
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationAlcohol Screening and Brief Interventions of Women
Alcohol Screening and Brief Interventions of Women Competency #2 Midwest Regional Fetal Alcohol Syndrome Training Center Competency 2: Screening and Brief Interventions This competency addresses preventing
More informationIn Brief MICHIGAN. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
MICHIGAN Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males
More informationMVP/PREFERRED CARE GUIDELINE
MVP/PREFERRED CARE GUIDELINE MVP/Preferred Care Clinical Guideline Overview Screening Adolescents for Alcohol and Substance Abuse in Primary Care MVP Health Care/ Preferred Care, as part of its continuing
More informationCalifornia Society of Addiction Medicine (CSAM) Consumer Q&As
C o n s u m e r Q & A 1 California Society of Addiction Medicine (CSAM) Consumer Q&As Q: Is addiction a disease? A: Addiction is a chronic disorder, like heart disease or diabetes. A chronic disorder is
More informationIn Brief ARIZONA. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies
ARIZONA Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males
More informationUpdate January 2008. BadgerCare Plus Information for Providers. BadgerCare Plus Overview. Definition of the New Benefit. No.
Update January 2008 No. 2008-04 BadgerCare Plus Information for Providers To: All Providers, HMOs and Other Managed Care Programs Mental Health and Substance Abuse Screening, Preventive Mental Health Counseling,
More informationKarol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University
Benzodiazepines and the Pregnant Patient: Special Challenges Karol Kaltenbach, PhD Maternal Addiction Treatment Education and Research Jefferson Medical College Thomas Jefferson University Outline Introduction
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationA Guide for Hospitals and Health Care Providers Perinatal Substance Use: Promoting Healthy Outcomes
A Guide for Hospitals and Health Care Providers Perinatal Substance Use: Promoting Healthy Outcomes Virginia Legal Requirements and Health Care Practice Implications Perinatal Care To promote healthy maternal
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationAUDIT. The Alcohol Use Disorders Identification Test: Interview Version
AUDIT The Alcohol Use Disorders Identification Test: Interview Version Read questions as written and record answers carefully. Begin the AUDIT by saying Now I am going to ask you some questions about your
More informationPerinatal Substance Use: Promoting Healthy Outcomes
A Guide for Hospitals and Health Care Providers Perinatal Substance Use: Promoting Healthy Outcomes Virginia Legal Requirements and Health Care Practice Implications Perinatal Care To promote healthy maternal
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationMaternal and Child Health Issue Brief
Maternal and Child Health Issue Brief Substance Abuse among Women of Reproductive Age in Colorado September 14 9 Why is substance abuse an issue among women of reproductive age? Substance abuse poses significant
More informationL Sedative - Hypnotic Protocols.
gnidnats Orders etaipo Protocols REHTO MEDICAL MANAGEMENT ISUES,ycnangerP Adiction and Mental Health FO SUBSTANCES DURING PREGNANCY TABLE OF CONTENTS i",- PREFACE 1 INTRODUCTION NOISIMDA AND DISCHARGE
More informationPerformance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
More informationhttp://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx
http://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx Alcohol Abuse By Neva K.Gulsby, PA-C, and Bonnie A. Dadig, EdD, PA-C Posted on: April 18, 2013 Excessive
More informationWhat Health Professionals Know and Do About Alcohol and Other Drug Use During Pregnancy
What Health Professionals Know and Do About Alcohol and Other Drug Use During Pregnancy Trecia Wouldes, PhD Department of Psychological Medicine A Research Report in Collaboration with Executive Summary
More informationSubstance Abuse Treatment and Child Welfare
Substance Abuse Treatment and Child Welfare Robert Morrison, Executive Director of the National Association of State Alcohol and Drug Abuse Directors (NASADAD) NASADAD Members Every state and territory
More informationStatewide Risk Screening Program for Pregnant Women: SBIRT Program
Statewide Risk Screening Program for Pregnant Women: SBIRT Program Louisiana Community/State Collaborative Michael Kudla,, M.D., FACOG Mary Craig, RN, MSN, MS February 22, 2007 Objectives Participants
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Women, Alcohol and Other Drugs, and Pregnancy Background The American Society of Addiction Medicine (ASAM) is deeply committed to the prevention
More informationImportant facts to remember
Important facts to remember If you re pregnant or trying to get pregnant, or if you know someone who is, there are several important points to remember: See a healthcare professional regularly. Get plenty
More informationChapter 388-877B WAC CHEMICAL DEPENDENCY SERVICES. Section One--Chemical Dependency--Detoxification Services
Chapter 388-877B WAC CHEMICAL DEPENDENCY SERVICES Section One--Chemical Dependency--Detoxification Services WAC 388-877B-0100 Chemical dependency detoxification services--general. The rules in WAC 388-877B-0100
More informationMEDICALLY MONITORED ACUTE TREATMENT SERVICES. Brief Guide for Providers
MEDICALLY MONITORED ACUTE TREATMENT SERVICES Brief Guide for Providers Introduction: Pregnant women are a priority population for substance abuse treatment services. The Bureau of Substance Abuse Services
More informationScreening, Brief Intervention, Referral, and Treatment (SBIRT) in Psychiatry
Screening, Brief Intervention, Referral, and Treatment (SBIRT) in Psychiatry Steve Martino, Ph.D. The SBIRT Training in Yale Residency Programs (SAMHSA 1U79Ti020253-01; PI: Gail D Onofrio, M.D.) At Issue
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationVENTURA COUNTY ALCOHOL & DRUG PROGRAMS
VENTURA COUNTY ALCOHOL & DRUG PROGRAMS women s services Helping women recover (805) 981-9200 1911 Williams Drive, Oxnard, CA 93036 www.venturacountylimits.org recovery VCBH ALCOHOL & DRUG PROGRAMS WOMEN
More informationScreening Patients for Substance Use in Your Practice Setting
Screening Patients for Substance Use in Your Practice Setting Learning Objectives By the end of this session, participants will Understand the rationale for universal screening. Identify potential health
More informationChapter 3: Healthy Start Risk Screening
Introduction Healthy Start legislation requires that all pregnant women and infants be offered screening for risk factors that may affect their pregnancy, health, or development. The prenatal and infant
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationStates In Brief Substance Abuse and Mental Health Issues At-A-Glance
kentucky States In Brief Substance Abuse and Mental Health Issues At-A-Glance A Short Report from the Office of Applied Studies Prevalence of Illicit Substance 1 and Alcohol Use The National Survey on
More informationVermont PRAMS Data Brief
Prenatal Counseling part 3 Alcohol, Tobacco & Drugs This is a report on the Pregnancy Risk Assessment Monitoring System (PRAMS), a survey conducted on a sample of Vermont women with live births since 2001.
More informationEstablished in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
More informationAlcohol & Chemical Dependence. Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma
Alcohol & Chemical Dependence Chisoo Choi, M.D. Internal Medicine Consultant Brookhaven Hospital Tulsa, Oklahoma Objectives Increased awareness of alcohol and chemical dependence problems Hallmarks of
More informationDartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***
Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft*** This content, sorted by LCME competencies is intended to
More informationThe Benefits of a Creating a Healthy Work Environment
Eaton County Substance Abuse Advisory Group (ECSAAG) Barry-Eaton District Health Department The Benefits of a Creating a Healthy Work Environment This presentation includes: Harmful affects of alcohol,
More informationHOPE Helping Opiate- Addicted Pregnant women Evolve
HOPE Helping Opiate- Addicted Pregnant women Evolve Medical Director: Michael P. Marcotte, MD TriHealth-Good Samaritan Hospital Cincinnati Ohio MHAS MOMs Grant 2014-2016 Ohio MHAS MOMs Grant 2014-2016
More informationTom Freese, PhD Sherry Larkins, PhD Clayton Chau, MD (Planner) - Medical Director Behavioral Services; L.A. Care Health Plan
Tom Freese, PhD Sherry Larkins, PhD Clayton Chau, MD (Planner) - Medical Director Behavioral Services; L.A. Care Health Plan UCLA Integrated Substance Abuse Programs UCLA David Geffen School of Medicine,
More informationStates In Brief. The National Survey on Drug Use and Health. texas. Prevalence of Illicit Substance 1 and Alcohol Use
texas States In Brief Substance Abuse and Mental Health Issues At-A-Glance a short Report from the Office of applied studies Prevalence of Illicit Substance 1 and Alcohol Use The National Survey on Drug
More informationNew Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid
Update December 2009 No. 2009-96 Affected Programs: BadgerCare Plus, Medicaid To: All Providers, HMOs and Other Managed Care Programs New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare
More informationUCLA Screening and Brief Intervention Training
UCLA Screening and Brief Intervention Training For Alcohol Reduction or Cessation Client Centered Care Western Regional Training Center on Fetal Alcohol Spectrum Disorders Materials provided through funding
More informationTitle: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
More informationGreetings from Denmark. Janni Niclasen, psychologist PhD Assistant professor Institute of Psychology University of Copenhagen Denmark
Janni Niclasen, psychologist PhD Assistant professor Institute of Psychology University of Copenhagen Denmark Who drinks and how much: 5.5 million people in Denmark Well-fare state World happiness report
More informationSubstance abuse and the nurse practitioner role: the client, the care, & the cost. Bonnie A. Franckowiak, DNP, FNP, CARN-AP NPAM / 2014
Substance abuse and the nurse practitioner role: the client, the care, & the cost Bonnie A. Franckowiak, DNP, FNP, CARN-AP NPAM / 2014 Objectives: After completion of this session, the learner will: 1.
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationOutline Substance Abuse Screening in Pregnancy
Outline Substance Abuse Screening in Pregnancy Allison S. Bryant, MD, MPH Department of Obstetrics, Gynecology & RS University of California, San Francisco Antepartum and Intrapartum Management June 7,
More informationTreatment of Opioid Dependence in Pregnancy
Treatment of Opioid Dependence in Pregnancy Jessica Young, MD Assistant Professor Department of Obstetrics and Gynecology Vanderbilt University Medical Center Disclosures I have no conflicts of interest
More informationSection IX Special Needs & Case Management
SPECIAL NEEDS & CASE MANAGEMENT Section IX Special Needs & Case Management Special Needs and Case Management 180 Integrated Care Management/Complex Case Management The Case Management/Care Coordination
More informationMeena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department
Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department 271 Neighborhood Statistical Areas 55 Community Statistical Areas 26 Zip Codes Characteristic Baltimore City
More informationFurther Discussion of Comprehensive Theory of Substance Abuse Prevention March, 2011
Further Discussion of Comprehensive Theory of Substance Abuse Prevention March, 2011 The prime dichotomy between profoundly challenged children and socially influenced teens may be similar to some other
More informationIf you re with child, be without alcohol. No amount of alcohol is safe to drink during pregnancy.
Alcohol & Pregnancy If you re with child, be without alcohol. No amount of alcohol is safe to drink during pregnancy. www.withchildwithoutalcohol.com 3 Introduction Many things we hear about pregnancy
More informationPregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research
Pregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research Hendree E. Jones Associate Professor, Department of Psychiatry Johns Hopkins University Outline I. World view
More informationFDA Presentation: Maternal Perspective on Opioid Medication Assisted Therapy
FDA Presentation: Maternal Perspective on Opioid Medication Assisted Therapy Lorraine A. Milio, M.D. Obstetrical Director Center for Addiction and Pregnancy Assistant Professor Maternal-Fetal Medicine
More informationMental Health. Health Equity Highlight: Women
Mental Health Background A person s ability to carry on productive activities and live a rewarding life is affected not only by physical health but by mental health. In addition, mental well-being can
More informationSubstance Use Disorder Screening and Testing 35-45-3
Policy The Department of Children and Families shall screen all adult and adolescent clients for indicators of substance use disorders and refer those in need of further assessment or treatment to an appropriate
More informationDo you drink or use other drugs? You could be harming more than just your health.
Do you drink or use other drugs? You could be harming more than just your health. Simple questions. Straight answers about the risks of alcohol and drugs for women. 1 Why is my health care provider asking
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationCo-Occurring Substance Use and Mental Health Disorders. Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs
Co-Occurring Substance Use and Mental Health Disorders Joy Chudzynski, PsyD UCLA Integrated Substance Abuse Programs Introduction Overview of the evolving field of Co-Occurring Disorders Addiction and
More informationChild Abuse and Neglect AAP Policy Recommendations
Child Abuse and Neglect AAP Policy Recommendations When Inflicted Skin Injuries Constitute Child Abuse Committee on Child Abuse and Neglect PEDIATRICS Vol. 110 No. 3 September 2002, pp. 644-645 Recommendations
More informationFlagship Priority: Mental Health and Substance Abuse
10 Colorado s winnable battles Flagship Priority: Mental Health and Substance Abuse ELEVATING HEALTH AND ENVIRONMENT Mental and emotional well-being is essential to shaping a state of health for Coloradans.
More informationA Descriptive Study of Depression, Substance Abuse, and Intimate Partner Violence Among Pregnant Women
A Descriptive Study of Depression, Substance Abuse, and Intimate Partner Violence Among Pregnant Women 1 OVERVIEW This presentation is based on the study of pregnant women enrolled in the Augusta Partnership
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationPregnancy and Substance Abuse
Pregnancy and Substance Abuse Introduction When you are pregnant, you are not just "eating for two." You also breathe and drink for two, so it is important to carefully consider what you put into your
More informationAlcohol and Drug Abuse Treatment Centers
Division of State Operated Healthcare Facilities Alcohol and Drug Abuse Treatment Centers Jenny Wood Interim ADATC Team Leader HHS LOC Mental Health Subcommittee February 24, 2014 ADATC Locations R.J.
More informationChapter 13: Transition and Interagency Agreements
Healthy Start Standards & Guidelines 2007 Chapter 13: Transition and Interagency Agreements Introduction Transition is movement or change from one environment to another. Transition activities are a critical
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationViolence Assessment and Follow-up In Public Health Data Sets
Violence Assessment and Follow-up In Public Health Data Sets Background Summer, 2012 This project was initiated to explore existing data on assessment of violence in the lives of women seeking services
More information